4basebio
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of 4basebio generated cash of -$6,178,000, which is less than the previous year. Cash used in financing activities reached the amount of $6,425,000 last year. Net change in cash is therefore -$1,282,000.

Cash Flow

4basebio PLC (LSE:4BB.L): Cash Flow
2019 -269K -203K 487K
2020 -1.02M 1.44M 14.42M
2021 -2.74M -1.51M -467K
2022 -4.70M -1.94M 1.24M
2023 -6.17M -1.49M 6.42M

4BB.L Cash Flow Statement (2019 – 2023)

2023 2022 2021 2020 2019
Cash at beginning of period
4.35M9.58M15.00M80K69K
Operating activities
Net income
-7.66M-5.15M-3.23M-719K-423K
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
709K431K320K277K251K
Stock-based compensation expense
0128K80K00
Deferred income tax benefit 0128K80K00
Changes in operating assets and liabilities:
Accounts receivable, net
-109K140K-126K91K116K
Inventories
-202K30K-34K-24K13K
Accounts payable
695K-2K615K-876K-167K
Cash generated by operating activities
-6.17M-4.70M-2.74M-1.02M-269K
Investing activities
Purchases Of Investments
00000
Investments In Property Plant And Equipment
-871K-1.94M-1.51M-849K-203K
Acquisitions Net
0002.29M0
Cash generated by investing activities
-1.49M-1.94M-1.51M1.44M-203K
Financing activities
Common Stock Issued
2K0015.62M0
Payments for dividends
00000
Repurchases of common stock
00000
Repayments of term debt
6.58M1.41M-331K-1.02M0
Cash used in financing activities
6.42M1.24M-467K14.42M487K
Net Change In Cash
-1.28M-5.23M-5.41M14.92M11K
Cash at end of period
3.06M4.35M9.58M15.00M80K
Data sourceData sourceData sourceData sourceData source